Almost Half Of US Adults Face Stress - This Company Believes Its Wearable Tech Is The Answer By Margaret Jackson, Benzinga
Los Angeles, California | October 14, 2022 08:44 AM Eastern Daylight Time
Maybe you have a Garmin or an Apple Watch to help you track how far you run or ride your bike and how much your heart rate increases when you exercise.
These devices are great for helping you achieve your fitness goals, but they don’t actually do anything to improve your mental well-being.
But now a watch-like device that’s designed to relieve stress is under development.
Los Angeles-based TruBrain’s wearable uses the vibrotherapy technology used in hospitals to soothe the user’s nervous system with safe, microsonic waves that increase blood flow, activate neurons and enhance neurotransmitter activity.
TruBrain’s unobtrusive Wearable device can be worn on the wrist or ankle and is a safe and effective method to nudge the parasympathetic nervous response in healthy adults.
“Our mission is to empower people to do their best thinking,” TruBrain Founder and CEO Chris Thompson said. “The problems we’re trying to solve are stress and anxiety. That will clear the runway for you to focus more, relax and get better sleep.”
In terms of the physical and emotional toll of increased stress, nearly half of US adults (49%) report their behavior has been negatively affected, according to the American Psychological Association. A staggering 94% of workers reported feeling stress at work.
With that data and the rapidly growing wearable market, Thompson believes that TruBrain’s Wearable, built by neuroscientists, is set up to succeed.
The global wearable technology market is expected to be worth $410.2 billion by 2026 growing at a compound annual growth rate of 31.2% driven by the prevalence of chronic diseases and obesity.
“We’ve reached profitability, and we have $18 million in historical sales,” Thompson said. “While this hardware is new for us, we’ve developed significant supply chain capabilities over the years, and we plan to apply some of those same principles to the wearable device space.
In addition to the Wearable still in development, TruBrain offers a line of nootropics blended to increase verbal fluency, avoid distractions and boost mental output. Their products are made by neuroscientists and based on decades of clinical research and brainwave measurements.
TruBrain’s most popular product is its 1-ounce nootropic drinks, which its website describes as “personalized brain food.” The drinks are formulated to help with sleep, relieve anxiety and fight procrastination and distractions. The company also offers brain fuel in the form of capsules, bars and powder sticks.
“We are super excited about the potential of the wearables category, starting with this version in development,” Thompson said. “Our new launches are meant to be additive to our core product line — not to cannibalize our products that are doing well in the market already. The beauty is it allows customers to test more options and angles to see what works best for their unique brain.”
TruBrain is raising money on StartEngine to support the development of the Wearable. StartEngine allows nonaccredited investors to buy shares with under a $500 investment.
TruBrain is a profitable brand in high-performance cognitive nutrition with over $18 million in lifetime sales. We deliver patent-pending brain food designed by neuroscientists to enhance your memory, focus, sleep, and more. Our personalized formulas will empower you to be the best version of your unique self.
Benzinga may receive monetary compensation from the issuer, or its agency, for publicizing the offering of the issuer’s securities. This content is for informational purposes only and is not intended to be investing advice. This is a paid ad. Please see 17b disclosure linked in the campaign page for more information.TruBrain's Reg A+ offering is made available through StartEngine Primary, LLC, member FINRA /SIPC.This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment. For more information about this offering, please view TruBrain's offering circular and risks associated with this offering.
This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice.
TruBrain Investor Relations